Morton Brown Family Wealth’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9K | Hold |
450
| – | – | ﹤0.01% | 182 |
|
|
2025
Q1 | $10.9K | Buy |
450
+150
| +50% | +$3.62K | ﹤0.01% | 185 |
|
|
2024
Q4 | $12.1K | Hold |
300
| – | – | ﹤0.01% | 163 |
|
|
2024
Q3 | $19K | Hold |
300
| – | – | 0.01% | 136 |
|
|
2024
Q2 | $15K | Hold |
300
| – | – | 0.01% | 141 |
|
|
2024
Q1 | $24.6K | Sell |
300
-600
| -67% | -$49.2K | 0.01% | 113 |
|
|
2023
Q4 | $16.7K | Hold |
900
| – | – | 0.01% | 152 |
|
|
2023
Q3 | $9.96K | Hold |
900
| – | – | 0.01% | 124 |
|
|
2023
Q2 | $14.6K | Hold |
900
| – | – | 0.01% | 109 |
|
|
2023
Q1 | $15K | Hold |
900
| – | – | 0.01% | 111 |
|
|
2022
Q4 | $8.46K | Hold |
900
| – | – | 0.01% | 117 |
|
|
2022
Q3 | $2K | Hold |
900
| – | – | ﹤0.01% | 181 |
|
|
2022
Q2 | $3K | Hold |
900
| – | – | ﹤0.01% | 185 |
|
|
2022
Q1 | $3K | Hold |
900
| – | – | ﹤0.01% | 123 |
|
|
2021
Q4 | $4K | Buy |
+900
| New | +$4K | ﹤0.01% | 143 |
|